Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
RMD Open|October 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension studyMaya H Buch, Daniel Aletaha, Bernard G Combe, et al.
Rheumatology (Oxford, England)|July 1, 2026
Use of advanced cardiovascular imaging in rheumatic immune-mediated inflammatory diseasesLeher Gumber, Mohammed Askari Meghji, Vishal Kakkar, et al.
Rheumatology (Oxford, England)|June 11, 2026
T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practiceInnocent C Anioke, Fatih Tastekin, Gulay Alp, et al.
BMJ Open|March 19, 2025
<b></b> robiotics <b></b> nfluencing <b></b> esponse of <b></b> ntibodies over <b></b> ime in <b></b> eniors after <b></b> VID-19 <b></b> accine (PIRATES-COV): a randomised controlled trial protocolJean-Charles Pasquier, Mélanie Plourde, Sheela Ramanathan, et al.
Frontiers in Medicine|April 5, 2021
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic SclerosisGianluca Bagnato, Erika Pigatto, Alessandra Bitto, et al.
Annals of the Rheumatic Diseases|September 22, 2022
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL SurveillanceChristina Charles-Schoeman, Maya H Buch, Maxime Dougados, et al.
Translational Psychiatry|December 1, 2020
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosisI B Chaudhry, M O Husain, A B Khoso, et al.
Annals of the Rheumatic Diseases|May 8, 2012
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?Richard J Wakefield, Maria Antonietta D'Agostino, Esperanza Naredo, et al.
Annals of the Rheumatic Diseases|September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular diseaseJon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
Postgraduate Medical Journal|July 24, 2012
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?Richard J Wakefield, Maria Antonietta D'Agostino, Esperanza Naredo, et al.
Pageof 21